STOCK TITAN

Shareholder plans Rule 144 sale of 5,685 Arvinas (ARVN) shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Arvinas, Inc. shareholder plans a modest Rule 144 stock sale. A holder has filed to sell 5,685 shares of Arvinas common stock through Morgan Stanley Smith Barney LLC on or around 02/13/2026 on the NASDAQ.

The filing lists an aggregate market value of 67,605.35 for the shares to be sold, compared with 64,224,294 Arvinas common shares outstanding. The shares were acquired on 02/13/2026 through settlement of vested restricted stock units from Arvinas, Inc.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Arvinas (ARVN) Form 144 filing disclose?

The Form 144 discloses a planned sale of 5,685 Arvinas common shares. The shares, valued in total at approximately 67,605.35, are intended to be sold on NASDAQ under Rule 144, providing notice of this potential resale to the market.

How many Arvinas (ARVN) shares are planned for sale under this Form 144?

The filing covers a planned sale of 5,685 shares of Arvinas common stock. These shares were acquired through settlement of vested restricted stock units and are to be sold through Morgan Stanley Smith Barney LLC as the broker.

What is the disclosed market value of the Arvinas (ARVN) shares to be sold?

The Form 144 lists an aggregate market value of 67,605.35 for the 5,685 Arvinas shares. This figure reflects the approximate value of the securities covered by the notice at the time it was prepared.

When are the Arvinas (ARVN) shares expected to be sold under Rule 144?

The notice states an approximate sale date of 02/13/2026 for the 5,685 Arvinas common shares. This date indicates when the shareholder expects to begin sales, subject to market conditions and Rule 144 requirements.

How were the Arvinas (ARVN) shares in this Form 144 acquired?

The shares were acquired on 02/13/2026 through settlement of vested restricted stock units from Arvinas, Inc. The filing specifies this non-cash equity compensation as the nature of the acquisition transaction for the 5,685 common shares.

How many Arvinas (ARVN) shares are outstanding compared to this planned sale?

The Form 144 notes 64,224,294 Arvinas common shares outstanding. The planned sale involves 5,685 shares, and the outstanding share count provides context for the relative size of this potential Rule 144 transaction.
Arvinas

NASDAQ:ARVN

ARVN Rankings

ARVN Latest News

ARVN Latest SEC Filings

ARVN Stock Data

734.73M
59.11M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN